UBS today reaffirms its sell investment rating on Meggitt PLC (LON:MGGT) and raised its price target to 530p (from 494p).

Broker Forecasts data provided by...

UBS today upgrades its investment rating on Bodycote PLC (LON:BOY) to buy (from neutral) and raised its price target to 1000p (from 845p).

Broker Forecasts...

UBS today reaffirms its neutral investment rating on BAE Systems Plc (LON:BA.) and raised its price target to 576p (from 530p).

Broker Forecasts data provided...

“There’s plenty for investors to fret about over the next few days and it doesn’t look like they’re feeling too positive about life, with the...

UBS today upgrades its investment rating on QinetiQ Group PLC (LON:QQ.) to neutral (from sell) and raised its price target to 335p (from 260p).

Broker...

UBS today reaffirms its buy investment rating on Rolls-Royce Group PLC (LON:RR.) and cut its price target to 938p (from 950p).

Broker Forecasts data provided...

Futura Medical said the European phase 3 clinical trial of its erectile dysfunction treatment had not met its primary goals versus a placebo.

FM57,...

Touch sensor manufacturer Zytronic posted a fall in annual profit, partly owing to weaker revenue from the gambling market.

Pre-tax profit for the year through...

UBS today reaffirms its buy investment rating on Melrose PLC (LON:MRO) and raised its price target to 285p (from 250p).

Broker Forecasts data provided by...

Management consultancy Mind Gym booked a rise in first-half profit, though its underlying performance was hurt by higher operating costs.

Pre-tax profit for the six...